FDA OKs New Drug To Boost COVID-19 Protection for Immunocompromised People

The FDA granted an emergency use authorization for Pemgarda, a monoclonal antibody for people who are immunocompromised to provide protection from COVID-19.

April 1, 2024 Today's top story FDA OKs New Drug To Boost COVID-19 Protection for Immunocompromised People The FDA granted an emergency use authorization for Pemgarda, a monoclonal antibody for people who are immunocompromised to provide protection from COVID-19. Read on       How Olivia Munn's Doctor Helped Calculate Her Breast Cancer Risk, Leading to Early Diagnosis Read ON   Puerto Rico Just Declared a Public Health Emergency Due to Dengue, What to Know Read ON   Arnold Schwarzenegger Recovering from Surgery After Getting a Pacemaker Read ON   More top Reads       Advertisement Start a custom weight loss program Noom helps you adopt healthy habits so you can lose weight and keep it off. GET STARTED

View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy  |  Unsubscribe Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health. © 2024 Healthline Media LLC 275 7th Ave., 24th Floor New York, NY 10001